Effect of whey supplementation on circulating C-reactive protein: A meta-analysis of randomized controlled trials

Nutrients

Volumn 7, Issue 2, 2015, Pages 1131-1143

  Zhou, Ling Mei ^a   Xu, Jia Ying ^a   Rao, Chun Ping ^b   Han, Shufen ^a   Wan, Zhongxiao ^a   Qin, Li Qiang ^a  

^a SOOCHOW UNIVERSITY   (China)

^b Suzhou Health College   (China)

Author keywords

C reactive protein; Meta analysis; Randomized controlled trial; Whey protein

Indexed keywords

C REACTIVE PROTEIN; MILK PROTEIN; BIOLOGICAL MARKER; WHEY PROTEIN;

CHRONIC OBSTRUCTIVE LUNG DISEASE; DIET SUPPLEMENTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; META ANALYSIS; METABOLIC SYNDROME X; NEPHELOMETRY; OBESITY; PREHYPERTENSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY ANALYSIS; WHEY; ADULT; BLOOD; DIET THERAPY; FEMALE; INFLAMMATION; MALE; YOUNG ADULT;

ADULT; BIOMARKERS; C-REACTIVE PROTEIN; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INFLAMMATION; MALE; MILK PROTEINS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WHEY PROTEINS; YOUNG ADULT;

EID: 84922584932     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7021131     Document Type: Review

References (41)

1. Sousa, G.T.; Lira, F.S.; Rosa, J.C.; de Oliveira, E.P.; Oyama, L.M.; Santos, R.V.; Pimentel, G.D. Dietary whey protein lessens several risk factors for metabolic diseases: A review. Lipids Health Dis. 2012, 11, 67.
2. Tong, X.; Li, W.; Xu, J.Y.; Han, S.; Qin, L.Q. Effects of whey protein and leucine supplementation on insulin sensitivity in non-obese insulin-resistant model rats. Nutrition 2014, 30, 1076-1080.
3. Qin, L.Q.; Xu, J.Y.; Dong, J.Y.; Zhao, Y.; van Bladeren, P.; Zhang, W. Lactotripeptides intake and blood pressure management: A meta-analysis of randomized controlled clinical trials. Nutr. Metab. Cardiovasc. Dis. 2013, 23, 395-402.
4. Broekhuizen, R.; Wouters, E.F.; Creutzberg, E.C.; Schols, A.M. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 2006, 61, 17-22.
5. Ridker, P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003, 107, 363-369.
6. Androulakis, E.; Tousoulis, D.; Papageorgiou, N.; Latsios, G.; Siasos, G.; Tsioufis, C.; Giolis, A.; Stefanadis, C. Inflammation in hypertension: Current therapeutic approaches. Curr. Pharm. Des. 2011, 17, 4121-4131.
7. Donath, M.Y. Targeting inflammation in the treatment of type 2 diabetes: Time to start. Nat. Rev. Drug Discov. 2014, 13, 465-476.
8. Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G.; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann. Intern. Med. 2009, 151, 264-269.
9. Jadad, A.R.; Moore, R.A.; Carroll, D.; Jenkinson, C.; Reynolds, D.J.; Gavaghan, D.J.; McQuay, H.J. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin. Trials 1996, 17, 1-12.
10. Higgins, J.; Green, S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration. Available online: http://www.cochrane-handbook.org (accessed on 20 June 2014).
11. Follmann, D.; Elliott, P.; Suh, I.; Cutler, J. Variance imputation for overviews of clinical trials with continuous response. J. Clin. Epidemiol. 1992, 45, 769-773.
12. Higgins, J.P.; Thompson, S.G.; Deeks, J.J.; Altman, D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327, 557-560.
13. DerSimonian, R.; Laird, N.P. Meta-analysis in clinical trials. Control Clin. Trials 1986, 7, 177-188.
14. Egger, M.; Davey Smith, G.; Schneider, M.; Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315, 629-634.
15. Duff, W.R.; Chilibeck, P.D.; Rooke, J.J.; Kaviani, M.; Krentz, J.R; Haines, D.M. The effect of bovine colostrum supplementation in older adults during resistance training. Int. J. Sport Nutr. Exerc. Metab. 2014, 24, 276-285.
16. Gouni-Berthold, I.; Schulte, D.M.; Krone, W.; Lapointe, J.F.; Lemieux, P.; Predel, H.G.; Berthold, H.K. The whey fermentation product malleable protein matrix decreases TAG concentrations in patients with the metabolic syndrome: A randomized placebo-controlled trial. Br. J. Nutr. 2012, 107, 1694-1706.
17. Petyaev, I.M.; Dovgalevsky, P.Y.; Klochkov, V.A.; Chalyk, N.E.; Kyle, N. Whey protein lycosome formulation improves vascular functions and plasma lipids with reduction of markers of inflammation and oxidative stress in prehypertension. Sci. World J. 2012, 2012, doi:10.1100/2012/269476.
18. Sugawara, K.; Takahashi, H.; Kashiwagura, T.; Yamada, K.; Yanagida, S.; Homma, M.; Dairiki, K.; Sasaki, H.; Kawagoshi, A.; Satake, M.; et al. Effect of anti-inflammatory supplementation with whey peptide and exercise therapy in patients with COPD. Respir. Med. 2012, 106, 1526-1534.
19. Weinheimer, E.M.; Conley, T.B.; Kobza, V.M.; Sands, L.P.; Lim, E.; Janle, E.M.; Campbell, W.W. Whey protein supplementation does not affect exercise training-induced changes in body composition and indices of metabolic syndrome in middle-aged overweight and obese adults. J. Nutr. 2012, 142, 1532-1539.
20. Laviolette, L.; Lands, L.C.; Dauletbaev, N.; Saey, D.; Milot, J.; Provencher, S.; LeBlanc, P.; Maltais, F. Combined effect of dietary supplementation with pressurized whey and exercise training in chronic obstructive pulmonary disease: A randomized, controlled, double-blind pilot study. J. Med. Food 2010, 13, 589-598.
21. Pal, S.; Ellis, V. The chronic effects of whey proteins on blood pressure, vascular function, and inflammatory markers in overweight individuals. Obesity 2010, 18, 1354-1359.
22. Lee, Y.M.; Skurk, T.; Hennig, M.; Hauner, H. Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension. Eur. J. Nutr. 2007, 46, 21-27.
23. Pins, J.J.; Keenan, J.M. Effects of whey peptides on cardiovascular disease risk factors. J. Clin. Hypertens. 2006, 8, 775-782.
24. Wang, C.; Yatsuya, H.; Tamakoshi, K.; Uemura, M.; Li, Y.; Wada, K.; Yamashita, K.; Kawaguchi, L.; Toyoshima, H.; Aoyama, A. Positive association between high-sensitivity C-reactive protein and incidence of type 2 diabetes mellitus in Japanese workers: 6-year follow-up. Diabetes Metab. Res. Rev. 2013, 29, 398-405.
25. Choi, J.L.; Joseph, L.; Pilote, L. Obesity and C-reactive protein in various populations: A systematic review and meta-analysis. Obes. Rev. 2013, 14, 232-244.
26. Buyken, A.E.; Goletzke, J.; Joslowski, G.; Felbick, A.; Cheng, G.; Herder, C.; Brand-Miller, J.C. Association between carbohydrate quality and inflammatory markers: Systematic review of observational and interventional studies. Am. J. Clin. Nutr. 2014, 99, 813-833.
27. Zhou, H.; Li, Y.; Huang, G.; Gu, X.; Zeng, J.; Li, Y.; Luo, C.; Ou, B.; Zhang, Y.; Wu, Z., et al. Interleukin 6 augments mechanical strain-induced C-reactive protein synthesis via the stretch-activated channel-nuclear factor κB signal pathway. Heart 2013, 99, 570-576.
28. Skurk, T.; van Harmelen, V.; Hauner, H. Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-κB. Arterioscler Thromb. Vasc. Biol. 2004, 24, 1199-1203.
29. Xiao, Y.; Haynes, W.L.; Michalek, J.E.; Russell, I.J. Elevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate. Rheumatol. Int. 2013, 33, 1259-1264.
30. Comassi, M.; Vitolo, E.; Pratali, L.; Del Turco, S.; Dellanoce, C.; Rossi, C.; Santini, E.; Solini, A. Acute effects of different degrees of ultra-endurance exercise on systemic inflammatory responses. Intern. Med. J. 2014, doi:10.1111/imj.12625.
31. Kerasioti, E.; Stagos, D.; Jamurtas, A.; Kiskini, A.; Koutedakis, Y.; Goutzourelas, N.; Pournaras, S.; Tsatsakis, A.M.; Kouretas, D. Anti-inflammatory effects of a special carbohydrate-whey protein cake after exhaustive cycling in humans. Food Chem. Toxicol. 2013, 61, 42-46.
32. Lands, L.C.; Iskandar, M.; Beaudoin, N.; Meehan, B.; Dauletbaev, N.; Berthiuame, Y. Dietary supplementation with pressurized whey in patients with cystic fibrosis. J. Med. Food 2010, 13, 77-82.
33. Bondia-Pons, I.; Ryan, L.; Martinez, J.A. Oxidative stress and inflammation interactions in human obesity. J. Physiol. Biochem. 2012, 68, 701-711.
34. Marshall, K. Therapeutic applications of whey protein. Altern. Med. Rev. 2004, 9, 136-156.
35. Zavorsky, G.S.; Kubow, S.; Grey, V.; Riverin, V.; Lands, L.C. An open-label dose-response study of lymphocyte glutathione levels in healthy men and women receiving pressurized whey protein isolate supplements. Int. J. Food. Sci. Nutr. 2007, 58, 429-436.
36. Kerasioti, E.; Stagos, D.; Priftis, A.; Aivazidis, S.; Tsatsakis, A.M.; Kouretas, D. Antioxidant effects of whey protein on muscle C2C12 cells. Food Chem. 2014, 155, 271-278.
37. Zemel, M.B.; Bruckbauer, A. Effects of a leucine and pyridoxine-containing nutraceutical on fat oxidation, and oxidative and inflammatory stress in overweight and obese subjects. Nutrients 2012, 4, 529-541.
38. Ricci-Cabello, I.; Herrera, M.O.; Artacho, R. Possible role of milk-derived bioactive peptides in the treatment and prevention of metabolic syndrome. Nutr. Rev. 2012, 70, 241-255.
39. Aihara, K.; Osaka, M.; Yoshida, M. Oral administration of milk casein-derived tripeptides Val-Pro-Pro attenuates high-fat diet-induced adipose tissue inflammation in mice. Br. J. Nutr. 2014, 112, 513-519.
40. Hirota, T.; Ohki, K.; Kawagishi, R.; Kajimoto, Y.; Mizuno, S.; Nakamura, Y.; Kitakaze, M. Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: Contribution of the inhibitory action of angiotensin-converting enzyme. Hypertens. Res. 2007, 30, 489-496.
41. Arnberg, K.; Larnkjar, A.; Michaelsen, K.F.; Jensen, S.M.; Hoppe, C.; Molgaard, C. Casein improves brachial and central aortic diastolic blood pressure in overweight adolescents: A randomized, controlled trial. J. Nutr. Sci. 2013, 2, 1-10.